Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03013491
Title A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors CytomX Therapeutics
Age Groups: adult | senior
Covered Countries USA | NLD | GBR | ESP

No variant requirements are available.